Medication info
Glea Tablet 2/500 mg

Glea Tablet 2/500 mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Withus Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201107273 · Approved 2011.09.28 · Insurance code 660702500

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Take this medicine 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience with gradually increasing the dose according to blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Ingredients

Manufacturer
Withus Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. The combination of glymepiride and metformin effectively improves blood sugar levels, assisting in diabetes management. Regular intake by patients enables smoother blood sugar control, greatly contributing to the maintenance of a healthy lifestyle.

How to take

Adult dose

Take this medicine 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience with gradually increasing the dose according to blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so caution is required. Particularly, if kidney function declines sharply, the drug may accumulate in the body, increasing the risk, necessitating regular checks of kidney function. If symptoms of dehydration, severe diarrhea, vomiting, or fever occur, medication should be temporarily stopped and medical advice should be sought. Furthermore, if taken with other medications, the risk of side effects may increase due to interactions, so it is important to inform a pharmacist or doctor. This medication is not administered to patients with insulin-dependent diabetes or acute metabolic acidosis, or those with severe liver or kidney dysfunction. It is also safer for pregnant or breastfeeding women to avoid this medication, and alternative treatments should be considered if necessary. Elderly patients, those with poor nutritional status, and patients who consume alcohol excessively are at a higher risk of hypoglycemia and lactic acidosis, so special caution should be exercised during treatment. During the initial phase of medication, gastrointestinal disturbances (diarrhea, nausea, vomiting, etc.) are common and generally improve on their own over time. Symptoms of hypoglycemia include headaches, extreme hunger, dizziness, and drowsiness; if such symptoms occur, immediate ingestion of sugar and consultation with healthcare personnel are advised. Lactic acidosis, though rare, is a serious side effect; if symptoms such as muscle pain, difficulty breathing, weakness, or abdominal pain occur, medication should be stopped immediately and emergency treatment obtained. While taking this medication, regular monitoring of blood sugar, kidney function, and blood tests should be conducted to track health status. In case of overdose, severe hypoglycemia or lactic acidosis may occur, so if suspected, immediate medical attention should be sought. Caution is necessary when driving or operating machinery due to possible decreased alertness from hypoglycemia. This medication should be stored out of reach of children in a safe place, and transferring it to another container should be avoided.

Side effects

  • Acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
Show 36 more
  • metallic taste
  • visual impairment
  • taste disorder
  • erythema
  • itching
  • urticaria
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythropenia
  • agranulocytosis
  • pancytopenia
  • decreased vitamin B12
  • peripheral neuropathy
  • megaloblastic anemia
  • increased liver enzymes
  • liver dysfunction
  • cholestasis
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity
  • decreased serum sodium concentration
  • hypothyroidism
  • magnesium deficiency during diarrhea
  • encephalopathy
  • hair loss
  • weight gain
  • abdominal pain
  • abdominal distension
  • palpitations
  • dizziness
  • nausea
  • leg edema
  • cardiac arrest
  • rectal carcinoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture; therefore, it must be stored in a tightly sealed container. It is also best to store it at room temperature, between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.